Harmony Biosciences Files 8-K: Director/Officer Changes & Compensation
Ticker: HRMY · Form: 8-K · Filed: Apr 3, 2025 · CIK: 1802665
| Field | Detail |
|---|---|
| Company | Harmony Biosciences Holdings, INC. (HRMY) |
| Form Type | 8-K |
| Filed Date | Apr 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, disclosure, officer-changes
TL;DR
Harmony Biosciences 8-K: Leadership changes and comp details filed April 3rd.
AI Summary
Harmony Biosciences Holdings, Inc. filed an 8-K on April 3, 2025, reporting changes in directors and officers, and compensatory arrangements. The filing also includes information related to Regulation FD and financial statements/exhibits. The company is incorporated in Delaware and its principal executive offices are located in Plymouth Meeting, PA.
Why It Matters
This filing indicates potential shifts in the company's leadership and executive compensation structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — This is a routine filing reporting standard corporate governance and disclosure items.
Key Players & Entities
- Harmony Biosciences Holdings, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Plymouth Meeting, PA (location) — Principal executive offices
FAQ
What specific items are being reported under Item Information?
The filing reports on the Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on April 2, 2025.
What is the company's Standard Industrial Classification code?
The SIC code is 2834, Pharmaceutical Preparations.
What is the company's fiscal year end?
The fiscal year end is December 31st.
What is the SEC file number for Harmony Biosciences Holdings, Inc.?
The SEC file number is 001-39450.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 3, 2025 regarding Harmony Biosciences Holdings, Inc. (HRMY).